Last reviewed · How we verify
NCT03637270
Protein Supplementation for Chronic Stroke Treatment
NA trial testing Dietary supplementation in Chronic Stroke in 114 participants. Completed in 3 April 2023.
1 April 2023
Quick facts
| Lead sponsor | Taipei Medical University WanFang Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 114 |
| Start date | 19 December 2018 |
| Primary completion | 1 April 2023 |
| Estimated completion | 3 April 2023 |
| Sites | 4 locations across Taiwan |
Drugs / interventions tested
- Dietary supplementation
- Exercise training
Conditions studied
- Chronic Stroke — all drugs for Chronic Stroke →
Sponsor
Taipei Medical University WanFang Hospital
Who can join
Adults 20 to 75, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke patients usually have difficulties with moving and are venerable to secondary problems such as sarcopenia and strength loss. These problems may accelerate the disability process during aging. It is well known that exercise helps to maintain or promote human fitness. This study is conducted to explore the beneficial effects of exercise and protein supplement on fitness and body composition among patients with chronic stroke.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nutritional therapy for reducing disability and improving activities of daily living in people after stroke.
Sakai K, Niimi M, Momosaki R, Hoshino E, et al · · 2024 · cited 4× · PMID 39145517 · DOI 10.1002/14651858.cd014852.pub2
Verify or expand the search:
- PubMed search for NCT03637270
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dietary supplementation
Trials testing the same drug.
- NCT06163001 — Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation · NA · completed
- NCT04097119 — HDL Function Dietary Supplement Safety and QOL · NA · unknown
Other recruiting trials for Chronic Stroke
Currently open trials in the same condition.
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07378774 — Constraint Induced Movement Therapy and Bilateral Training in Chronic Stroke · NA · recruiting
- NCT07353203 — Safety and Efficacy of Hip Assist Powered Exoskeleton for Gait Training in Patients With Late Subacute and Chronic Strok · NA · recruiting
- NCT07065292 — Plantar Sensation, Position Sense, and Weight-Bearing Asymmetry Related to Balance and Mobility Post-Stroke · recruiting
- NCT06286800 — Personalized Transcranial Direct Current Stimulation in Stroke Recovery · NA · recruiting
Other Taipei Medical University WanFang Hospital trials
Trials by the same sponsor.
- NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
- NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
- NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
- NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
- NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03637270 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
- Last refreshed: 8 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03637270.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing